In Prader-Willi syndrome, which of the following is increased?
Haversian system is seen in which type of bone tissue?
Which of the following is NOT a cyanotic heart disease?
Phase 2 of damage control surgery typically occurs during which phase of patient management?
Which of the following is NOT a component of the acute inflammatory response?
Memory T cells can be identified by using which of the following markers?
Which of the following conditions is associated with HLA-B27 in 90% of cases?
What pharmacokinetic change occurs in geriatric patients?
What is the half-life of Factor VIII?
Pharmacodynamics includes which of the following?
Explanation: **Explanation:** **Prader-Willi Syndrome (PWS)** is a complex genetic disorder caused by the loss of function of genes on the paternal chromosome **15q11-q13**. The hallmark of the syndrome is severe hyperphagia (uncontrollable hunger) leading to morbid obesity. **Why Ghrelin is Increased:** Ghrelin is an "orexigenic" (appetite-stimulating) hormone produced primarily by the P/D1 cells of the stomach. In PWS, there is a characteristic **elevation of circulating Ghrelin levels** (hyperghrelinemia) even before the onset of obesity [1]. This elevation is thought to be a primary driver of the persistent hunger and lack of satiety seen in these patients. Unlike simple obesity where ghrelin is usually suppressed, in PWS, it remains high, making it a high-yield diagnostic marker. **Why Other Options are Incorrect:** * **LH & FSH (Options A & B):** PWS is associated with **Hypogonadotropic Hypogonadism** due to hypothalamic dysfunction. Therefore, levels of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) are typically **decreased**, leading to genital hypoplasia and delayed puberty. * **TSH (Option C):** Central hypothyroidism can occur in PWS due to hypothalamic-pituitary axis dysfunction, meaning **TSH** levels are usually **low or inappropriately normal**, but not increased. **High-Yield Clinical Pearls for NEET-PG:** * **Genetics:** Paternal deletion of 15q11-q13 (most common) or Maternal Uniparental Disomy (UPD). * **Infancy:** Characterized by severe **hypotonia** ("floppy baby") and feeding difficulties. * **Childhood:** Transition to hyperphagia, obesity, short stature, and small hands/feet. * **Key Association:** High Ghrelin + Low GnRH (leading to low LH/FSH).
Explanation: The **Haversian system**, also known as an **Osteon**, is the fundamental functional unit of **compact (cortical) bone**. It consists of a central Haversian canal containing blood vessels and nerves, surrounded by concentric layers of mineralized matrix called lamellae [2]. Between these lamellae are lacunae containing osteocytes, which communicate via tiny channels called canaliculi. This dense, organized arrangement provides the structural strength required for the outer shell of long bones [1]. **Analysis of Options:** * **Cortical bone (Correct):** This is the dense outer layer of bone where Haversian systems are tightly packed to withstand mechanical stress [1]. * **Cancellous bone (Incorrect):** Also known as spongy or trabecular bone, it lacks true Haversian systems. Instead, it is composed of an irregular lattice of **trabeculae** [1]. Nutrients are absorbed via diffusion from the surrounding bone marrow spaces. * **Teeth (Incorrect):** While teeth contain mineralized tissues (enamel, dentin, cementum), they do not possess Haversian systems. Dentin contains "dentinal tubules," which are structurally distinct. * **Nail (Incorrect):** Nails are composed of hard **keratin** (a protein), not mineralized bone tissue, and thus have no cellular or vascular organization resembling an osteon. **High-Yield Clinical Pearls for NEET-PG:** * **Volkmann’s Canals:** These are horizontal canals that connect adjacent Haversian systems and carry blood vessels from the periosteum. * **Interstitial Lamellae:** These are the remnants of old Haversian systems found between intact osteons, representing the result of continuous bone remodeling. * **Woven Bone:** This is immature bone where collagen fibers are randomly arranged; it lacks Haversian systems and is seen during fetal development or fracture healing [2].
Explanation: ### Explanation Congenital heart diseases (CHD) are broadly classified into **Cyanotic** (Right-to-Left shunt) and **Acyanotic** (Left-to-Right shunt) [1]. **Why Patent Ductus Arteriosus (PDA) is the correct answer:** PDA is an **acyanotic** heart disease. It involves a persistent communication between the descending aorta and the pulmonary artery [1]. Since the pressure in the aorta is higher than in the pulmonary artery, blood shunts from **Left to Right**. This results in increased pulmonary blood flow but does not cause systemic deoxygenation (cyanosis) initially [1]. **Analysis of Incorrect Options:** * **Tetralogy of Fallot (TOF):** The most common cyanotic CHD after infancy [1]. It involves pulmonary stenosis and a VSD, leading to a **Right-to-Left shunt** and systemic cyanosis. * **Tricuspid Atresia:** A cyanotic condition where the tricuspid valve fails to develop. Systemic venous blood must pass through an ASD to the left side to reach the lungs via a VSD or PDA, resulting in obligatory mixing and cyanosis. * **Eisenmenger’s Complex:** This occurs when a long-standing acyanotic shunt (like VSD or PDA) causes pulmonary hypertension, eventually **reversing the shunt** from Left-to-Right to **Right-to-Left**, thereby causing "tardive" or late-onset cyanosis. **NEET-PG High-Yield Pearls:** * **The 5 T’s of Cyanotic CHD:** **T**OF, **T**ransposition of Great Arteries (TGA), **T**ricuspid Atresia, **T**otal Anomalous Pulmonary Venous Return (TAPVR), and **T**runcus Arteriosus. * **PDA Murmur:** Characterized by a **machinery-type continuous murmur**, loudest at the left infraclavicular area. * **Drug of Choice:** **Indomethacin** or Ibuprofen (NSAIDs) are used to close a PDA in neonates, while **Prostaglandin E1** is used to keep it open in ductal-dependent lesions.
Explanation: **Explanation:** Damage Control Surgery (DCS) is a staged surgical strategy designed to manage patients with severe physiological derangement (the "Lethal Triad" of acidosis, hypothermia, and coagulopathy). It prioritizes physiological restoration over anatomical completeness [1]. **1. Why the Correct Answer is Right:** **Phase 2 (ICU Resuscitation)** is the "physiological cooling-off" period. Once the initial surgery (Phase 1) has achieved hemorrhage and contamination control, the patient is transferred to the ICU. The primary goals here are **rewarming, correction of coagulopathy, and hemodynamic stabilization** using advanced monitoring and massive transfusion protocols. This phase typically lasts 24 to 48 hours. **2. Analysis of Incorrect Options:** * **Option A (Pre-hospital):** This is often referred to as "Phase 0." It involves rapid transport and "scoop and run" tactics but is not part of the formal surgical phases. * **Option C (Resuscitation in the OR):** This is **Phase 1**. The focus is on immediate life-saving maneuvers: laparotomy, control of bleeding (packing/shunting), and control of contamination [1]. Definitive repairs are deferred. * **Option D (Definitive Repair):** This is **Phase 3**. Once the patient’s physiology is normalized in the ICU, they return to the OR for pack removal and definitive repair of injuries. **High-Yield Clinical Pearls for NEET-PG:** * **The Lethal Triad:** Hypothermia, Acidosis, and Coagulopathy. DCS aims to break this cycle. * **Phase 1 Goal:** "Get in, get out." Surgery should ideally be completed within 60–90 minutes. * **Abdominal Compartment Syndrome:** A common complication to monitor during Phase 2 due to aggressive fluid resuscitation and temporary abdominal closure [2]. * **Phase 4:** Some classifications include a Phase 4, which involves formal abdominal wall closure.
Explanation: The inflammatory response is categorized into **acute** and **chronic** phases based on the duration and the nature of the cellular infiltrate [1]. **1. Why Granuloma formation is the correct answer:** Granuloma formation is a hallmark of **chronic inflammation**, specifically chronic granulomatous inflammation. It is a protective mechanism where the body attempts to wall off an offending agent that is difficult to eradicate (e.g., *Mycobacterium tuberculosis*, sarcoidosis, or foreign bodies). It consists of a microscopic aggregation of epithelioid macrophages, multinucleated giant cells, and a rim of lymphocytes. Since it involves tissue remodeling and prolonged cellular recruitment, it is not part of the acute phase. **2. Analysis of Incorrect Options:** * **Vasodilation (A):** This is one of the earliest vascular changes in acute inflammation [1]. It is mediated by histamine and nitric oxide, leading to increased blood flow (rubor) and heat (calor) [1]. * **Exudation (B):** Acute inflammation involves increased vascular permeability, allowing protein-rich fluid (exudate) to move into the extravascular space, resulting in tissue swelling (edema) [1]. * **Neutrophilic response (C):** Neutrophils are the "first responders" and the characteristic cell type of acute inflammation. They are recruited via chemotaxis to perform phagocytosis and release antimicrobial peptides. ### NEET-PG High-Yield Pearls * **Cardinal Signs of Acute Inflammation:** Rubor (redness), Calor (heat), Tumor (swelling), Dolor (pain), and Functio Laesa (loss of function) [1]. * **Cellular Shift:** Acute = Neutrophils; Chronic = Macrophages, Lymphocytes, and Plasma cells [2]. * **Granuloma Components:** The presence of **Epithelioid histiocytes** is the defining feature required to call a lesion a granuloma. * **Vascular Hallmark:** The most common mechanism of vascular leakage in acute inflammation is **endothelial cell contraction** (immediate transient response).
Explanation: The identification of T cell subsets relies on the expression of different isoforms of CD45 (Leukocyte Common Antigen), a tyrosine phosphatase essential for T-cell receptor signaling. **Why CD45RO is correct:** CD45RO is the shortest isoform of the CD45 molecule. It is characteristically expressed on **Memory T cells** (both CD4+ and CD8+). When a naive T cell encounters an antigen and becomes activated, it undergoes alternative splicing of the CD45 gene, switching from the expression of high-molecular-weight isoforms (like RA) to the low-molecular-weight **CD45RO** isoform. This marker remains on the cell surface, allowing these cells to respond more rapidly upon re-exposure to the same antigen. **Analysis of Incorrect Options:** * **CD45RA:** This is the marker for **Naive T cells** (cells that have not yet encountered their specific antigen). * **CD45RB:** This isoform is typically expressed on B cells, naive T cells, and a subset of memory cells, but it is not a specific diagnostic marker for memory T cells in the context of competitive exams. * **CD45RC:** This is primarily expressed on B cells and specific subsets of CD8+ T cells; it is not the hallmark of memory T cells. **High-Yield Clinical Pearls for NEET-PG:** * **CD45 (LCA):** Used in immunohistochemistry to differentiate lymphomas (CD45 positive) from carcinomas (CD45 negative). * **Memory T-cell subtypes:** * *Central Memory T cells (Tcm):* Express **CCR7** and L-selectin (CD62L); they home to lymph nodes. * *Effector Memory T cells (Tem):* Lack CCR7; they home to peripheral tissues. * **Mnemonic:** "R**A** is for **A**mateur (Naive), R**O** is for **O**ld (Memory)."
Explanation: The association between Human Leukocyte Antigen (HLA) alleles and specific diseases is a high-yield topic for NEET-PG. **Ankylosing Spondylitis (AS)** shows the strongest association with **HLA-B27**, with approximately **90-95%** of patients testing positive for this marker [1]. AS is a chronic inflammatory arthritis primarily affecting the sacroiliac joints and the axial skeleton, leading to characteristic "bamboo spine" on imaging. **Analysis of Options:** * **Ankylosing Spondylitis (Correct):** The 90% association is a diagnostic hallmark. While HLA-B27 is present in only 8% of the general population, its presence significantly increases the relative risk of developing AS [1]. * **Rheumatoid Arthritis:** This is primarily associated with **HLA-DR4** (specifically the "shared epitope"). It is not linked to HLA-B27. * **Psoriasis:** While Psoriatic Arthritis is part of the seronegative spondyloarthropathy group, the association with HLA-B27 is much lower (around 40-50%). Psoriasis itself is more strongly linked to **HLA-Cw6**. * **Reiter’s Syndrome (Reactive Arthritis):** This condition is also associated with HLA-B27, but the prevalence is lower than in AS, typically ranging from **60% to 80%**. **Clinical Pearls for NEET-PG:** 1. **Seronegative Spondyloarthropathies (PEAR):** Remember the mnemonic **P**soriatic arthritis, **E**nteropathic arthritis, **A**nkylosing spondylitis, and **R**eactive arthritis. All are associated with HLA-B27 and are Rheumatoid Factor (RF) negative [1]. 2. **Schober’s Test:** Used clinically to assess the restriction of lumbar flexion in AS. 3. **Other HLA Associations:** * HLA-B51: Behcet’s disease. * HLA-DQ2/DQ8: Celiac disease. * HLA-DR3/DR4: Type 1 Diabetes Mellitus.
Explanation: The physiological process of aging leads to a progressive decline in the functional reserve of most organ systems [1]. In geriatric patients, the most significant and predictable pharmacokinetic change is a **reduction in renal clearance**. **1. Why Renal Clearance is the Correct Answer:** With advancing age, there is a physiological decrease in the number of functional nephrons, renal blood flow, and Glomerular Filtration Rate (GFR) [1]. Even in the absence of overt kidney disease, renal function can decline by approximately 1% per year after age 40. This leads to a prolonged half-life and increased plasma concentrations of drugs primarily excreted by the kidneys (e.g., Digoxin, Gentamicin, Lithium), necessitating dose adjustments to avoid toxicity. **2. Analysis of Incorrect Options:** * **A. Gastric Absorption:** While aging causes increased gastric pH and delayed gastric emptying, the overall *extent* of drug absorption (bioavailability) remains largely unchanged for most drugs. * **B. Liver Metabolism:** Hepatic blood flow and mass decrease with age, affecting the "first-pass" metabolism of some drugs. However, Phase II reactions (conjugation) remain relatively preserved, making liver metabolism less predictably altered than renal clearance. * **D. Hypersensitivity:** This is a pharmacodynamic or idiosyncratic reaction rather than a standard pharmacokinetic parameter (ADME). **3. NEET-PG High-Yield Pearls:** * **Cockcroft-Gault Formula:** Always use this to estimate CrCl in elderly patients, as serum creatinine alone may appear normal due to decreased muscle mass (sarcopenia) [1]. * **Vd Changes:** Elderly patients have increased body fat and decreased total body water. This **increases the Volume of Distribution (Vd)** for lipid-soluble drugs (e.g., Diazepam) and **decreases Vd** for water-soluble drugs (e.g., Digoxin). * **Rule of Thumb:** "Start low and go slow" is the clinical mantra for geriatric prescribing.
Explanation: **Explanation:** The correct answer is **8 hours**. Factor VIII (Anti-Hemophilic Factor) is a critical cofactor in the intrinsic pathway of the coagulation cascade. In the plasma, Factor VIII circulates bound to **von Willebrand Factor (vWF)**, which stabilizes it and protects it from rapid proteolytic degradation. * **Why 8 hours is correct:** The biological half-life of infused Factor VIII in patients with Hemophilia A typically ranges from **8 to 12 hours** [1]. For NEET-PG purposes, 8 hours is the standard "lower limit" value often tested. This relatively short half-life necessitates twice-daily dosing (every 12 hours) during acute bleeding episodes or major surgery to maintain therapeutic levels above 30-50%. **Analysis of Incorrect Options:** * **A (4 hours):** This is too short for Factor VIII. However, **Factor VII** has the shortest half-life of all clotting factors (approx. 4–6 hours), which is a frequent high-yield comparison. * **C (24 hours):** This is too long for Factor VIII. Factors like Prothrombin (Factor II) have a longer half-life (approx. 60–72 hours). * **D (30 hours):** This does not correspond to Factor VIII. Fibrinogen (Factor I) has a much longer half-life of about 3–5 days. **High-Yield Clinical Pearls for NEET-PG:** * **Shortest Half-life:** Factor VII (4–6 hours). This is why the PT/INR rises first in liver failure or Vitamin K deficiency. * **Longest Half-life:** Factor II (Prothrombin). * **Hemophilia A:** X-linked recessive deficiency of Factor VIII [1]. * **Cryoprecipitate:** Contains Factor VIII, Fibrinogen, vWF, and Factor XIII. * **Desmopressin (DDAVP):** Used in mild Hemophilia A as it releases stored Factor VIII and vWF from endothelial Weibel-Palade bodies [2].
Explanation: **Explanation:** Pharmacology is broadly divided into two main branches: **Pharmacokinetics** and **Pharmacodynamics**. **Why the correct answer is right:** **Pharmacodynamics** is defined as "what the drug does to the body." It focuses on the biochemical and physiological effects of drugs and their **mechanism of action**. This includes drug-receptor interactions, dose-response relationships, and the sequence of events leading to a therapeutic or toxic effect. Since "Mechanism of action" describes how a drug produces its effect at the cellular or molecular level, it falls squarely under pharmacodynamics. **Why the incorrect options are wrong:** Options A, B, and C (Elimination, Excretion, and Absorption) are components of **Pharmacokinetics**. Pharmacokinetics is "what the body does to the drug." It is traditionally remembered by the mnemonic **ADME**: * **Absorption:** Movement of the drug from the site of administration to the bloodstream. * **Distribution:** Movement of the drug from the blood to various tissues. * **Metabolism:** Biotransformation of the drug (primarily in the liver). * **Excretion/Elimination:** Removal of the drug or its metabolites from the body (primarily via kidneys). **High-Yield NEET-PG Pearls:** * **Pharmacodynamics** = **D**rug → Body (Effect/Mechanism). * **Pharmacokinetics** = **B**ody → Drug (ADME). * **Receptors** are the most common targets for pharmacodynamic action. * **Therapeutic Index (TI):** A key pharmacodynamic parameter calculated as $LD_{50} / ED_{50}$, representing the safety margin of a drug. * **Bioavailability:** A key pharmacokinetic parameter representing the fraction of an administered drug that reaches systemic circulation unchanged.
Organization of the Nervous System
Practice Questions
Spinal Cord Anatomy
Practice Questions
Brainstem Anatomy
Practice Questions
Cerebellum
Practice Questions
Diencephalon
Practice Questions
Cerebral Cortex
Practice Questions
Basal Ganglia
Practice Questions
Limbic System
Practice Questions
Cranial Nerves
Practice Questions
Autonomic Nervous System
Practice Questions
Neural Pathways and Tracts
Practice Questions
Neurovascular Anatomy
Practice Questions
Get full access to all questions, explanations, and performance tracking.
Start For Free